Seagate Technology (STX) 10-Q 27 Jan 22 2022 Q2 Quarterly report Financial data

Cover page

Cover page - shares	6 Months Ended
	Dec. 31, 2021	Jan. 24, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	001-31560
Entity Incorporation, State or Country Code	L2
Entity Tax Identification Number	98-1597419
Entity Address, Address Line One	38/39 Fitzwilliam Square
Entity Address, City or Town	Dublin 2
Entity Address, Country	IE
Entity Address, Postal Zip Code	D02 NX53
City Area Code	(353) (1)
Local Phone Number	234-3136
Title of 12(b) Security	Ordinary Shares, par value $0.00001 per share
Trading Symbol	STX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Smaller Reporting Company	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		218,898,339
Entity Registrant Name	Seagate Technology Holdings plc
Entity Central Index Key	0001137789
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--07-02

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2021	Jul. 02, 2021
Current assets:
Cash and cash equivalents	$ 1,535,000,000	$ 1,209,000,000
Accounts receivable, net	1,399,000,000	1,158,000,000
Inventories	1,287,000,000	1,204,000,000
Other current assets	229,000,000	208,000,000
Total current assets	4,450,000,000	3,779,000,000
Property, equipment and leasehold improvements, net	2,216,000,000	2,181,000,000
Goodwill	1,237,000,000	1,237,000,000
Other intangible assets, net	19,000,000	29,000,000
Deferred Income Tax Assets, Net	1,126,000,000	1,117,000,000
Other assets, net	327,000,000	332,000,000
Total Assets	9,375,000,000	8,675,000,000
Current liabilities:
Accounts payable	1,812,000,000	1,725,000,000
Accrued employee compensation	228,000,000	282,000,000
Accrued warranty	62,000,000	61,000,000
Accrued expenses	655,000,000	608,000,000
Total current liabilities	2,992,000,000	2,921,000,000
Long-term accrued warranty	82,000,000	75,000,000
Other non-current liabilities	149,000,000	154,000,000
Long-term Debt, Excluding Current Maturities	5,626,000,000	4,894,000,000
Total Liabilities	8,849,000,000	8,044,000,000
Shareholders’ Equity:
Ordinary shares and additional paid-in capital	7,084,000,000	6,977,000,000
Accumulated other comprehensive loss	(25,000,000)	(41,000,000)
Accumulated deficit	(6,533,000,000)	(6,305,000,000)
Total Equity	526,000,000	631,000,000
Total Liabilities and Equity	9,375,000,000	8,675,000,000
Less: current portion of debt	$ 235,000,000	$ 245,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Income Statement [Abstract]
Revenue	$ 3,116	$ 2,623	$ 6,231	$ 4,937
Cost of revenue	2,168	1,927	4,327	3,645
Product development	228	221	461	444
Marketing and administrative	136	122	269	240
Amortization of intangibles	3	3	6	6
Restructuring and other, net	1	2	2	3
Total operating expenses	2,536	2,275	5,065	4,338
Income from operations	580	348	1,166	599
Interest income	1	0	1	1
Interest expense	(62)	(52)	(121)	(102)
Other Nonoperating Income (Expense)	(5)	(5)	1	14
Other expense, net	(66)	(57)	(119)	(87)
Income before income taxes	514	291	1,047	512
Provision for income taxes	13	11	20	9
Net income	$ 501	$ 280	$ 1,027	$ 503
Net income per share:
Basic (in dollars per share)	$ 2.27	$ 1.12	$ 4.58	$ 1.99
Diluted (in dollars per share)	$ 2.23	$ 1.12	$ 4.50	$ 1.97
Number of shares used in per share calculations:
Basic (in shares)	221	249	224	253
Diluted (in shares)	225	251	228	255
Cash dividends declared per ordinary share (in dollars per share)	$ 0.70	$ 0.67	$ 1.37	$ 1.32

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 501	$ 280	$ 1,027	$ 503
Change in net unrealized (losses) gains on cash flow hedges:
Net unrealized (losses) gains arising during the period	11	12	2	16
Losses (gains) reclassified into earnings	9	(2)	12	(2)
Net change	20	10	14	14
Change in unrealized components of post-retirement plans:
Net unrealized gains arising during the period	0	(1)		(1)
Losses reclassified into earnings	0	1		2
Net change	0	0	2	1
Foreign currency translation adjustments
Foreign currency translation adjustments	0	0	0	15
Other comprehensive loss	20	10	16	30
Comprehensive income	$ 521	$ 290	$ 1,043	$ 533

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021
OPERATING ACTIVITIES
Net income	$ 1,027	$ 503
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	212	195
Share-based compensation	70	58
Deferred income taxes	0	(13)
Other non-cash operating activities, net	22	4
Changes in operating assets and liabilities:
Accounts receivable, net	(241)	315
Inventories	(83)	(176)
Accounts payable	63	(75)
Accrued employee compensation	(54)	(18)
Accrued expenses, income taxes and warranty	40	(36)
Other assets and liabilities	(39)	13
Net cash provided by operating activities	1,017	770
INVESTING ACTIVITIES
Acquisition of property, equipment and leasehold improvements	(212)	(270)
Proceeds from sale of investments	34	11
Purchases of investments	(18)	(4)
Net cash used in investing activities	(196)	(263)
FINANCING ACTIVITIES
Redemption and repurchase of debt	(481)	(21)
Dividends to shareholders	(304)	(334)
Repurchases of ordinary shares	(896)	(1,068)
Taxes paid related to net share settlement of equity awards	(45)	(32)
Proceeds from issuance of long-term debt	1,200	1,000
Proceeds from issuance of ordinary shares under employee stock plans	37	40
Net cash used in financing activities	(495)	(430)
Increase in cash, cash equivalents and restricted cash	326	77
Cash, cash equivalents and restricted cash at the beginning of the period	1,211	1,724
Cash, cash equivalents and restricted cash at the end of the period	1,537	1,801
Proceeds from (Payments for) Other Financing Activities	$ (6)	$ (15)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]
Beginning balance (in shares) at Jul. 03, 2020		257
Beginning balance at Jul. 03, 2020	$ 1,787	$ 0	$ 6,757	$ (66)	$ (4,904)
Increase (Decrease) in Stockholders' Equity
Net income	503				503
Other comprehensive income	30			30
Issuance of ordinary shares under employee stock plans (In shares)		3
Issuance of ordinary shares under employee share plans	40		40
Repurchases of ordinary shares (in shares)		(19)
Repurchases of ordinary shares	(1,068)				$ (1,068)
Tax withholding related to vesting of restricted stock units (in shares)					(1)
Tax withholding related to vesting of restricted share units	(32)				$ (32)
Dividends to shareholders ($0.67 per ordinary share)	(328)				(328)
Share-based compensation	58		58
Ending balance (in shares) at Jan. 01, 2021		240
Ending balance at Jan. 01, 2021	990	$ 0	6,855	(36)	(5,829)
Increase (Decrease) in Stockholders' Equity
Issuance of ordinary shares under employee stock plans (In shares)		3
Beginning balance (in shares) at Oct. 02, 2020		258
Beginning balance at Oct. 02, 2020	1,821	$ 0	6,814	(46)	(4,947)
Increase (Decrease) in Stockholders' Equity
Net income	280				280
Other comprehensive income	10			10
Issuance of ordinary shares under employee stock plans (In shares)		0
Issuance of ordinary shares under employee share plans	11		11
Repurchases of ordinary shares (in shares)		(18)
Repurchases of ordinary shares	(1,000)				$ (1,000)
Tax withholding related to vesting of restricted stock units (in shares)					0
Tax withholding related to vesting of restricted share units	(1)				$ (1)
Dividends to shareholders ($0.67 per ordinary share)	(161)				(161)
Share-based compensation	30		30
Ending balance (in shares) at Jan. 01, 2021		240
Ending balance at Jan. 01, 2021	990	$ 0	6,855	(36)	(5,829)
Increase (Decrease) in Stockholders' Equity
Issuance of ordinary shares under employee stock plans (In shares)		0
Beginning balance (in shares) at Jul. 02, 2021		227
Beginning balance at Jul. 02, 2021	631	$ 0	6,977	(41)	(6,305)
Increase (Decrease) in Stockholders' Equity
Net income	1,027				1,027
Other comprehensive income	$ 16			16
Issuance of ordinary shares under employee stock plans (In shares)		3
Issuance of ordinary shares under employee share plans			37
Repurchases of ordinary shares (in shares)	(10)	(10)
Repurchases of ordinary shares	$ (905)				$ (905)
Tax withholding related to vesting of restricted stock units (in shares)	(1)				(1)
Tax withholding related to vesting of restricted share units	$ (45)				$ (45)
Dividends to shareholders ($0.67 per ordinary share)	(305)				(305)
Share-based compensation	70		70
Ending balance (in shares) at Dec. 31, 2021		219
Ending balance at Dec. 31, 2021	526	$ 0	7,084	(25)	(6,533)
Increase (Decrease) in Stockholders' Equity
Issuance of ordinary shares under employee stock plans (In shares)		3
Beginning balance (in shares) at Oct. 01, 2021		225
Beginning balance at Oct. 01, 2021	601	$ 0	7,044	(45)	(6,398)
Increase (Decrease) in Stockholders' Equity
Net income	501				501
Other comprehensive income	20			20
Issuance of ordinary shares under employee stock plans (In shares)		0
Issuance of ordinary shares under employee share plans	4		4
Repurchases of ordinary shares (in shares)		(5)
Repurchases of ordinary shares	(480)				$ (480)
Tax withholding related to vesting of restricted stock units (in shares)					(1)
Tax withholding related to vesting of restricted share units	(2)				$ (2)
Dividends to shareholders ($0.67 per ordinary share)	(154)				(154)
Share-based compensation	36		36
Ending balance (in shares) at Dec. 31, 2021		219
Ending balance at Dec. 31, 2021	$ 526	$ 0	$ 7,084	$ (25)	$ (6,533)
Increase (Decrease) in Stockholders' Equity
Issuance of ordinary shares under employee stock plans (In shares)		0

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Organization Seagate Technology Holdings plc (“STX”) and its subsidiaries (collectively, unless the context otherwise indicates, the “Company”) is a leading provider of data storage technology and solutions. Its principal products are hard disk drives, commonly referred to as disk drives, hard drives or HDDs. In addition to HDDs, the Company produces a broad range of data storage products including solid state drives (“SSDs”), solid state hybrid drives (“SSHDs”), storage subsystems, as well as a scalable edge-to-cloud mass data platform that includes data transfer shuttles and a storage-as-a-service cloud. HDDs are devices that store digitally encoded data on rapidly rotating disks with magnetic surfaces. HDDs continue to be the primary medium of mass data storage due to their performance attributes, reliability, high capacities, superior quality and cost effectiveness. Complementing existing storage architectures, SSDs use integrated circuit assemblies as memory to store data, and most SSDs use NAND flash memory. In contrast to HDDs and SSDs, SSHDs combine the features of SSDs and HDDs in the same unit, containing a high-capacity HDD and a smaller SSD acting as a cache to improve performance of frequently accessed data. The Company’s HDD products are designed for mass capacity storage and legacy markets. Mass capacity storage involves well-established use cases—such as hyperscale data centers and public clouds as well as emerging use cases. Legacy markets include markets the Company continues to service but that it does not plan to invest in significantly. The Company’s HDD and SSD product portfolio includes Serial Advanced Technology Attachment, Serial Attached SCSI and Non-Volatile Memory Express based designs to support a wide variety of mass capacity and legacy applications. The Company’s system portfolio includes storage subsystems for enterprises, cloud service providers, scale-out storage servers and original equipment manufacturers (“OEMs”). Engineered for modularity, mobility, capacity and performance, these solutions include the Company’s enterprise HDDs and SSDs, enabling customers to integrate powerful, scalable storage within legacy environments or build new ecosystems from the ground up in a secure, cost-effective manner. The Company’s Lyve portfolio provides a simple, cost-efficient and secure way to manage massive volumes of data across the distributed enterprise. The Lyve platform includes a shuttle solution that enables enterprises to transfer massive amounts of data from endpoints to the core cloud, a storage-as-a-service cloud that provides frictionless mass capacity storage at the metro edge, a converged object storage solution enabling efficient capture and consolidation of massive data sets and Cortx, an open-source object storage software optimized for mass capacity and data intensive workloads. Basis of Presentation and Consolidation The unaudited Condensed Consolidated Financial Statements of the Company and the accompanying notes were prepared in accordance with United States (“U.S.”) Generally Accepted Accounting Principles (“GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and all its wholly-owned and majority-owned subsidiaries, after elimination of intercompany transactions and balances. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s condensed consolidated financial statements and accompanying notes. These estimates and assumptions include the impact of the COVID-19 pandemic. Actual results could differ materially from those estimates. The methods, estimates and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results the Company reports in its condensed consolidated financial statements. The Company’s consolidated financial statements for the fiscal year ended July 2, 2021 are included in its Annual Report on Form 10-K, as filed with the U.S. Securities and Exchange Commission (“SEC”) on August 6, 2021. The Company believes that the disclosures included in these unaudited condensed consolidated financial statements, when read in conjunction with its consolidated financial statements as of July 2, 2021, and the notes thereto, are adequate to make the information presented not misleading. The results of operations and the cash flows for the three and six months ended December 31, 2021 are not necessarily indicative of the results to be expected for any subsequent interim period or for the Company’s fiscal year ending July 1, 2022. Fiscal Year The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. In fiscal years with 53 weeks, the first quarter consists of 14 weeks and the remaining quarters consist of 13 weeks each. The three and six months ended December 31, 2021 consisted of 13 and 26 weeks, respectively, and the three and six months ended January 1, 2021 consisted of 13 and 26 weeks, respectively. Fiscal year 2022, which ends on July 1, 2022, is comprised of 52 weeks and fiscal year 2021, which ended on July 2, 2021, was comprised of 52 weeks. The fiscal quarters ended December 31, 2021, October 1, 2021 and January 1, 2021, are also referred to herein as the “December 2021 quarter”, the “September 2021 quarter” and the “December 2020 quarter”, respectively. Summary of Significant Accounting Policies There have been no material changes to the Company’s significant accounting policies disclosed in Note 1. Basis of Presentation and Summary of Significant Accounting Policies of “Financial Statements and Supplementary Data” contained in Part II, Item 8. of the Company’s Annual Report on Form 10-K for the fiscal year ended July 2, 2021, as filed with the SEC on August 6, 2021. Recently Adopted Accounting Pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12 (ASC Topic 740), Simplifying the Accounting for Income Taxes. This ASU simplifies accounting for income taxes by removing certain exceptions to the general principles and amending existing guidance to improve consistent application. This ASU became effective and the Company adopted the guidance in the September 2021 quarter. The adoption of this ASU did not have an impact on the Company’s condensed consolidated financial statements. In July 2021, the FASB issued ASU 2021-05 (ASC Topic 842), Lessors—Certain Leases with Variable Lease Payments. This ASU requires lessors to classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease and the lessor would have otherwise recognized a day-one loss. The Company adopted the guidance in the September 2021 quarter on a prospective basis. The adoption of this ASU did not have an impact on the Company’s condensed consolidated financial statements. Recently Issued Accounting Pronouncements

Balance Sheet Information

Balance Sheet Information	6 Months Ended
	Dec. 31, 2021
Disclosure Text Block Supplement [Abstract]
Balance Sheet Information	Balance Sheet Information Available-for-sale Debt Securities The following table summarizes, by major type, the fair value and amortized cost of the Company’s available-for-sale debt investments as of December 31, 2021 and July 2, 2021: December 31, July 2, (Dollars in millions) Amortized Cost Unrealized Gain/(Loss) Fair Value Amortized Cost Unrealized Gain/(Loss) Fair Value Available-for-sale debt securities: Money market funds $ 435 $ — $ 435 $ 552 $ — $ 552 Time deposits and certificates of deposit 1 — 1 1 — 1 Other debt securities 36 — 36 18 — 18 Total $ 472 $ — $ 472 $ 571 $ — $ 571 Included in Cash and cash equivalents $ 434 $ 551 Included in Other current assets 2 2 Included in Other assets, net 36 18 Total $ 472 $ 571 As of both December 31, 2021 and July 2, 2021, the Company’s Other current assets included $2 million in restricted cash and investments held as collateral at banks for various performance obligations. As of December 31, 2021 and July 2, 2021, the Company had no material available-for-sale debt securities that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined no impairment related to credit losses for available-for-sale debt securities as of December 31, 2021 and July 2, 2021. The fair value and amortized cost of the Company’s investments classified as available-for-sale debt securities as of December 31, 2021, by remaining contractual maturity were as follows: (Dollars in millions) Amortized Cost Fair Value Due in less than 1 year $ 436 $ 436 Due in 1 to 5 years 28 28 Due in 6 to 10 years — — Thereafter 8 8 Total $ 472 $ 472 Cash, Cash Equivalents and Restricted Cash The following table provides a summary of cash, cash equivalents and restricted cash reported within the Company’s Condensed Consolidated Balance Sheets that reconciles to the corresponding amount in the Company’s Condensed Consolidated Statements of Cash Flows: (Dollars in millions) December 31, July 2, January 1, July 3, Cash and cash equivalents $ 1,535 $ 1,209 $ 1,799 $ 1,722 Restricted cash included in Other current assets 2 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 1,537 $ 1,211 $ 1,801 $ 1,724 Inventories The following table provides details of the inventory balance sheet item: (Dollars in millions) December 31, July 2, Raw materials and components $ 474 $ 375 Work-in-process 463 443 Finished goods 350 386 Total inventories $ 1,287 $ 1,204 Property, Equipment and Leasehold Improvements, net The components of property, equipment and leasehold improvements, net, were as follows: (Dollars in millions) December 31, July 2, Property, equipment and leasehold improvements $ 10,521 $ 10,378 Accumulated depreciation and amortization (8,305) (8,197) Property, equipment and leasehold improvements, net $ 2,216 $ 2,181 Accrued Expenses The following table provides details of the accrued expenses balance sheet item: (Dollars in millions) December 31, July 2, Dividends payable $ 154 $ 153 Other accrued expenses 501 455 Total $ 655 $ 608 Accumulated Other Comprehensive Loss (“AOCL”) The components of AOCL, net of tax, were as follows: (Dollars in millions) Unrealized Gains/(Losses) on Cash Flow Hedges Unrealized Gains/(Losses) on Post-Retirement Plans Foreign Currency Translation Adjustments Total Balance at July 2, 2021 $ (18) $ (22) $ (1) $ (41) Other comprehensive income before reclassifications 2 1 — 3 Amounts reclassified from AOCL 12 1 — 13 Other comprehensive income 14 2 — 16 Balance at December 31, 2021 $ (4) $ (20) $ (1) $ (25) Balance at July 3, 2020 $ (24) $ (26) $ (16) $ (66) Other comprehensive income (loss) before reclassifications 16 (1) — 15 Amounts reclassified from AOCL (2) 2 15 15 Other comprehensive income 14 1 15 30 Balance at January 1, 2021 $ (10) $ (25) $ (1) $ (36)

Debt

Debt	6 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Debt	During the six months ended January 1, 2021, $9 million aggregate principal amount of the 2022 Notes were repurchased for cash at a premium to their principal amount, plus accrued and unpaid interest. 2023 Notes . During the six months ended January 1, 2021, $5 million aggregate principal amount of the 2023 Notes were repurchased for cash at a premium to their principal amount, plus accrued and unpaid interest. The Company recorded a loss of $1 million on repurchases during the six months ended January 1, 2021, which is included in Other, net in the Company’s Condensed Consolidated Statements of Operations. Credit Agreement The Company’s subsidiary, Seagate HDD Cayman, entered into a credit agreement on February 20, 2019, which was amended on September 16, 2019, January 13, 2021, May 18, 2021 and October 14, 2021 (the “Credit Agreement”). Prior to the October 14, 2021 amendment, the Credit Agreement provided a term loan facility in an aggregate principal amount of $500 million and a $1.725 billion senior unsecured revolving credit facility (“Revolving Credit Facility”). The September 2019 Term Loan had a final maturity date of September 16, 2025 and the Revolving Credit Facility had a final maturity of February 20, 2024. On September 17, 2019, Seagate HDD Cayman borrowed the $500 million principal amount under the September 2019 Term Loan. On October 14, 2021, STX and Seagate HDD Cayman entered into an amendment to the Credit Agreement (“Fifth Amendment”), which provides for a new term loan facility in the aggregate principal amount of $1.2 billion that was extended in two tranches of $600 million each (“Term Loan A1” and “Term Loan A2” and together the “Term Loans”). Term Loan A1 and Term Loan A2 were each drawn in full on the closing date for the Fifth Amendment. The proceeds of the Term Loans may be used for general corporate purposes, to refinance or repay the September 2019 Term Loan and to refinance or repay the 2022 Notes. Term Loan A1 bears interest at a rate of LIBOR plus a variable margin ranging from 1.125% to 2.375% that will be determined based on the corporate credit rating of the Company. Term Loan A1 is repayable in quarterly installments beginning on December 31, 2022 and has a final maturity date of September 16, 2025. Term Loan A2 bears interest at a rate of LIBOR plus a variable margin ranging from 1.25% to 2.5% that will be determined based on the corporate credit rating of the Company. Term Loan A2 is repayable in quarterly installments beginning on December 31, 2022 and has a final maturity date of July 30, 2027. On October 14, 2021, Seagate HDD Cayman utilized part of the proceeds of Term Loan A1 to fully repay the $475 million principal amount outstanding of the September 2019 Term Loan. In addition, pursuant to the Fifth Amendment, the maturity date for the revolving loan commitments under the Revolving Credit Facility was extended until October 14, 2026, the revolving commitments were increased to $1.75 billion and the interest rate margins for the revolving loans were amended to LIBOR plus a variable margin ranging from 1.125% to 2.375% that will be determined based on the corporate credit rating of the Company. STX and certain of its material subsidiaries, including STUC, fully and unconditionally guarantee both the Revolving Credit Facility and the Term Loans. The Credit Agreement includes three financial covenants: (1) interest coverage ratio, (2) total leverage ratio and (3) a minimum liquidity amount. The Company was in compliance with the covenants as of December 31, 2021 and expects to be in compliance for the next 12 months. As of December 31, 2021, no borrowings (including swingline loans) were outstanding and no commitments were utilized for letters of credit issued under the Revolving Credit Facility.

Income Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company recorded income tax provisions of $13 million and $20 million for the three and six months ended December 31, 2021, respectively. The discrete items in the income tax provision were not material for the three months ended December 31, 2021. The income tax provision for the six months ended December 31, 2021 included approximately $9 million of net discrete tax benefit , primarily associated with net excess tax benefits related to share-based compensation expense. During the six months ended December 31, 2021 , the Company’s unrecognized tax benefits excluding interest and penalties increased by approximately $7 million to $115 million , substantially all of which would impact the effective tax rate, if recognized, subject to certain future valuation allowance reversals. During the twelve months beginning January 1, 2022 , the Company expects that its unrecognized tax benefits could be reduced by an immaterial amount , as a result of the expiration of certain statutes of limitation. The Company recorded income tax provisions of $11 million and $9 million for the three and six months ended January 1, 2021, respectively. The discrete items in the income tax provision were not material for the three months ended January 1, 2021. The income tax provision for the six months ended January 1, 2021 included approximately $11 million of net discrete tax benefit, primarily associated with net excess tax benefits related to share-based compensation expense and postponement of the previously enacted United Kingdom tax rate change in the quarter ended October 2, 2020. The Company’s income tax provision recorded for the three and six months ended December 31, 2021 and the three and six months ended January 1, 2021 differed from the provision for income taxes that would be derived by applying the Irish statutory rate of 25% to income before income taxes, primarily due to the net effect of tax benefits related to (i) non-Irish earnings generated in jurisdictions that are subject to tax incentive programs and are considered indefinitely reinvested outside of Ireland and (ii) current year generation of research credits.

Restructuring and Exit Costs

Restructuring and Exit Costs	6 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Exit Costs	Restructuring and Exit Costs For the three and six months ended December 31, 2021, the Company recorded restructuring charges of $1 million and $2 million, respectively. For the three and six months ended January 1, 2021, the Company recorded restructuring charges of $2 million and $3 million, respectively. The Company’s restructuring plans are comprised primarily of charges related to workforce reduction costs and facilities and other exit costs. All restructuring charges are reported in Restructuring and other, net on the Company’s Condensed Consolidated Statements of Operations. The following tables summarize the Company’s restructuring activities under the Company’s active restructuring plans: (Dollars in millions) Workforce Reduction Costs Facilities and Other Exit Costs Total Accrual balances at July 2, 2021 $ 2 $ 6 $ 8 Restructuring charges 2 — 2 Cash payments (2) (2) (4) Accrual balances at December 31, 2021 $ 2 $ 4 $ 6 Total costs incurred inception to date as of December 31, 2021 $ 65 $ 23 $ 88 Total expected charges to be incurred as of December 31, 2021 $ — $ 8 $ 8

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company is exposed to foreign currency exchange rate, interest rate, and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. As of December 31, 2021, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.2 billion, of which $600 million will mature in September 2025 and $600 million will mature in July 2027. The Company’s accounting policies for these instruments are based on whether the instruments are classified as designated or non-designated hedging instruments. The Company records all derivatives on its Condensed Consolidated Balance Sheets at fair value. The changes in the fair value of highly effective designated cash flow hedges are recorded in Accumulated other comprehensive loss until the hedged item is recognized in earnings. Derivatives that are not designated as hedging instruments or are not assessed to be highly effective are adjusted to fair value through earnings. The amount of net unrealized loss on cash flow hedges was $4 million and $18 million as of December 31, 2021 and as of July 2, 2021, respectively. As of December 31, 2021, the amount of existing net losses related to cash flow hedges recorded in Accumulated other comprehensive loss included a net loss of $10 million that is expected to be reclassified to earnings within twelve months. The Company de-designates its cash flow hedges when the forecasted hedged transactions affect earnings or it is probable the forecasted hedged transactions will not occur in the initially identified time period. At such time, the associated gains and losses deferred in Accumulated other comprehensive loss on the Company’s Condensed Consolidated Balance Sheets are reclassified into earnings and any subsequent changes in the fair value of such derivative instruments are immediately reflected in earnings. The Company recognized a net loss of $6 million and $3 million in Cost of revenue and Interest expense, respectively, related to the loss of hedge designation on discontinued cash flow hedges during the three months ended December 31, 2021. The Company recognized a net loss of $8 million and $4 million in Cost of revenue and Interest expense, respectively, related to the loss of hedge designation on discontinued cash flow hedges during the six months ended December 31, 2021. The Company recognized a net gain of $4 million in Cost of revenue related to the loss of hedge designation on discontinued cash flow hedges during the three and six months ended January 1, 2021. The Company recognized a net loss of $2 million and $4 million in Other, net related to the loss of hedge designation on discontinued cash flow hedges during the three and six months ended January 1, 2021, respectively. Other derivatives not designated as hedging instruments consist of foreign currency forward exchange contracts that the Company uses to hedge the foreign currency exposure on forecasted expenditures denominated in currencies other than the U.S. dollar. The Company recognizes gains and losses on these contracts, as well as the related costs in Other, net on its Condensed Consolidated Statements of Operations. The following tables show the total notional value of the Company’s outstanding foreign currency forward exchange contracts as of December 31, 2021 and July 2, 2021. All of the foreign currency forward exchange contracts mature within 12 months. As of December 31, 2021 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 170 $ 54 Thai Baht 130 42 Chinese Renminbi 84 22 British Pound Sterling 65 18 $ 449 $ 136 As of July 2, 2021 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 172 $ 43 Thai Baht 131 46 Chinese Renminbi 73 21 British Pound Sterling 54 16 $ 430 $ 126 The Company is subject to equity market risks due to changes in the fair value of the notional investments selected by its employees as part of its non-qualified deferred compensation plan: the Seagate Deferred Compensation Plan (the “SDCP”). In fiscal year 2014, the Company entered into a Total Return Swap (“TRS”) in order to manage the equity market risks associated with the SDCP’s liabilities. The Company pays a floating rate, based on LIBOR plus an interest rate spread, on the notional amount of the TRS. The TRS is designed to substantially offset changes in the SDCP’s liabilities due to changes in the value of the investment options made by employees. As of December 31, 2021, the notional investments underlying the TRS amounted to $133 million and the contract term was through January 2022, settled on a monthly basis, limiting counterparty performance risk. As of January 25, 2022, the contract term of the TRS was extended through January 2023. The Company did not designate the TRS as a hedge. Rather, the Company records all changes in the fair value of the TRS to earnings to offset the market value changes of the SDCP’s liabilities. The following tables show the Company’s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 31, 2021 and July 2, 2021: As of December 31, 2021 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Location Fair Value Balance Sheet Location Fair Value Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ 1 Accrued expenses $ (2) Interest rate swap Other current assets 2 Accrued expenses (5) Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets 1 Accrued expenses (3) Total derivatives $ 4 $ (10) As of July 2, 2021 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Location Fair Value Balance Sheet Location Fair Value Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ 1 Accrued expenses $ (5) Interest rate swap Other current assets — Accrued expenses (14) Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets 1 Accrued expenses (2) Total return swap Other current assets 2 Accrued expenses — Total derivatives $ 4 $ (21) The following tables show the effect of the Company’s derivative instruments on the Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2021: Amount of Gain/(Loss) Recognized in Income on Derivatives (Dollars in millions) Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Income on Derivatives For the Three Months For the Six Months Foreign currency forward exchange contracts Other, net $ 2 $ (2) Total return swap Operating expenses 7 6 (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) For the Three Months For the Six Months For the Three Months For the Six Months For the Three Months For the Six Months Foreign currency forward exchange contracts $ 4 $ (5) Cost of revenue $ (6) $ (8) Other, net $ — $ 1 Interest rate swap 7 7 Interest expense (3) (4) Interest expense — — The following tables show the effect of the Company’s derivative instruments on the Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Operations for the three and six months ended January 1, 2021 : (Dollars in millions) Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Income on Derivatives Amount of Gain/(Loss) Recognized in Income on Derivatives For the Three Months For the Six Months Foreign currency forward exchange contracts Other, net $ 6 $ 14 Total return swap Operating expenses $ 11 $ 16 (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) For the Three Months For the Six Months For the Three Months For the Six Months For the Three Months For the Six Months Foreign currency forward exchange contracts $ 11 $ 15 Cost of revenue $ 4 $ 4 Other, net $ 1 $ 1 Interest rate swap 1 1 Interest expense (2) (4) Interest expense — —

Fair Value

Fair Value	6 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company’s own assumptions of market participant valuation (unobservable inputs). A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 — Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 — Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 — Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively. Items Measured at Fair Value on a Recurring Basis The following tables present the Company’s assets and liabilities, by financial instrument type and balance sheet line item, that are measured at fair value on a recurring basis, excluding accrued interest components, as of: December 31, 2021 July 2, 2021 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (Dollars in millions) Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Assets: Money market funds $ 434 $ — $ — $ 434 $ 551 $ — $ — $ 551 Total cash equivalents 434 — — 434 551 — — 551 Restricted cash and investments: Money market funds 1 — — 1 1 — — 1 Time deposits and certificates of deposit — 1 — 1 — 1 — 1 Other debt securities — — 36 36 — — 18 18 Derivative assets — 4 — 4 — 4 — 4 Total assets $ 435 $ 5 $ 36 $ 476 $ 552 $ 5 $ 18 $ 575 Liabilities: Derivative liabilities $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21 Total liabilities $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21 December 31, 2021 July 2, 2021 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (Dollars in millions) Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Assets: Cash and cash equivalents $ 434 $ — $ — $ 434 $ 551 $ — $ — $ 551 Other current assets 1 5 — 6 1 5 — 6 Other assets, net — — 36 36 — — 18 18 Total assets $ 435 $ 5 $ 36 $ 476 $ 552 $ 5 $ 18 $ 575 Liabilities: Accrued expenses $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21 Total liabilities $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21 The Company classifies items in Level 1 if the financial assets consist of securities for which quoted prices are available in an active market. The Company classifies items in Level 2 if the financial asset or liability is valued using observable inputs. The Company uses observable inputs including quoted prices in active markets for similar assets or liabilities. Level 2 assets include: agency bonds, corporate bonds, commercial paper, municipal bonds, U.S. Treasuries, time deposits and certificates of deposit. These debt investments are priced using observable inputs and valuation models which vary by asset class. The Company uses a pricing service to assist in determining the fair value of all of its cash equivalents. For the cash equivalents in the Company’s portfolio, multiple pricing sources are generally available. The pricing service uses inputs from multiple industry-standard data providers or other third-party sources and various methodologies, such as weighting and models, to determine the appropriate price at the measurement date. The Company corroborates the prices obtained from the pricing service against other independent sources and, as of December 31, 2021, has not found it necessary to make any adjustments to the prices obtained. The Company’s derivative financial instruments are also classified within Level 2. The Company’s derivative financial instruments consist of foreign currency forward exchange contracts, interest rate swaps and the TRS. The Company recognizes derivative financial instruments in its condensed consolidated financial statements at fair value. The Company determines the fair value of these instruments by considering the estimated amount it would pay or receive to terminate these agreements at the reporting date. Items Measured at Fair Value on a Non-Recurring Basis From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under the equity method or the measurement alternative. If measured at fair value in the Condensed Consolidated Balance Sheets, these investments would generally be classified in Level 3 of the fair value hierarchy. For the investments that are accounted for under the equity method, the Company recorded an immaterial gain and a net gain of $3 million for the three and six months ended December 31, 2021, respectively. The Company recorded a net gain of $1 million and an immaterial gain for the three and six months ended January 1, 2021, respectively. The adjusted carrying value of the investments accounted for under the equity method amounted to $81 million and $78 million as of December 31, 2021 and July 2, 2021, respectively. For the investments that are accounted for under the measurement alternative, the Company recorded a net loss of $2 million and a net gain of $4 million for the three and six months ended December 31, 2021, respectively. The Company recorded a net loss of $7 million and a net gain of $16 million for the three and six months ended January 1, 2021, respectively, related to downward and upward adjustments due to observable price changes. As of December 31, 2021 and July 2, 2021, the carrying value of the Company’s strategic investments under the measurement alternative was $88 million and $117 million, respectively. Other Fair Value Disclosures The Company’s debt is carried at amortized cost. The estimated fair value of the Company’s debt is derived using the closing price of the same debt instruments as of the date of valuation, which takes into account the yield curve, interest rates and other observable inputs. Accordingly, these fair value measurements are categorized as Level 2. The following table presents the fair value and amortized cost of the Company’s debt in order of maturity: December 31, 2021 July 2, 2021 (Dollars in millions) Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value 4.25% Senior Notes due March 2022 $ 220 $ 221 $ 220 $ 224 4.75% Senior Notes due June 2023 541 565 541 578 4.875% Senior Notes due March 2024 499 530 499 544 4.75% Senior Notes due January 2025 479 515 479 529 4.875% Senior Notes due June 2027 504 554 504 561 4.091% Senior Notes due June 2029 463 521 461 519 3.125% Senior Notes due July 2029 500 490 500 488 4.125% Senior Notes due January 2031 500 522 499 513 3.375% Senior Notes due July 2031 500 489 500 487 5.75% Senior Notes due December 2034 489 567 489 566 LIBOR Based Term Loan A1 due September 2025 600 589 — — LIBOR Based Term Loan A2 due July 2027 600 592 — — LIBOR Based Term Loan due September 2025 — — 481 478 5,895 6,155 5,173 5,487 Less: unamortized debt issuance costs (34) — (34) — Debt, net of debt issuance costs 5,861 6,155 5,139 5,487 Less: current portion of debt (235) (236) (245) (249) Long-term debt, less current portion, net of debt issuance costs $ 5,626 $ 5,919 $ 4,894 $ 5,238

Equity

Equity	6 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Equity	Equity Share Capital The Company’s authorized share capital i s $13,500 and consists of 1,250,000,000 ordinary shares, par value $0.00001, of which 219,463,688 shares were outstanding as of December 31, 2021, and 100,000,000 preferred shares, par value $0.00001, of which none were issued or outstanding as of December 31, 2021. Ordinary shares —Holders of ordinary shares are entitled to receive dividends when declared by the Board of Directors. Upon any liquidation, dissolution, or winding up, after required payments are made to holders of preferred shares, any remaining assets will be distributed ratably to holders of the preferred and ordinary shares. Holders of shares are entitled to one vote per share on all matters upon which the ordinary shares are entitled to vote, including the election of directors. Preferred shares —The Company may issue preferred shares in one or more series, up to the authorized amount, without shareholder approval. The Board of Directors is authorized to establish from time to time the number of shares to be included in each series, and to fix the rights, preferences and privileges of the shares of each wholly unissued series and any of its qualifications, limitations or restrictions. The Board of Directors can also increase or decrease the number of shares of a series, but not below the number of shares of that series then outstanding, without any further vote or action by the shareholders. The Board of Directors may authorize the issuance of preferred shares with voting or conversion rights that could harm the voting power or other rights of the holders of the ordinary shares. The issuance of preferred shares, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of the Company and might harm the market price of its ordinary shares and the voting and other rights of the holders of ordinary shares. Repurchases of Equity Securities All repurchases are effected as redemptions in accordance with the Company’s Constitution. On May 14, 2021, STX’s Board of Directors resolved to adopt and continue the STUC Share Repurchase Program as its own and that the STX Board of Directors be authorized to effect the repurchase of STX ordinary shares in an amount equal to the remaining STUC Share Repurchase Program amount as of the effective time of the scheme of arrangement . As of December 31, 2021, $3.3 billion remained available for repurchase under the existing repurchase authorization limit. The following table sets forth information with respect to repurchases of ordinary shares during the six months ended December 31, 2021: (In millions) Number of Shares Repurchased Dollar Value of Shares Repurchased Repurchases of ordinary shares (1) 10 $ 905 Tax withholding related to vesting of equity awards 1 45 Total 11 $ 950

Revenue

Revenue	6 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The following table provides information about disaggregated revenue by sales channel and geographical region for the Company’s single reportable segment: For the Three Months Ended For the Six Months Ended (Dollars in millions) December 31, January 1, December 31, January 1, Revenues by Channel OEMs $ 2,178 $ 1,741 $ 4,465 $ 3,349 Distributors 562 475 1,069 842 Retailers 376 407 697 746 Total $ 3,116 $ 2,623 $ 6,231 $ 4,937 Revenues by Geography (1) Asia Pacific $ 1,433 $ 1,306 $ 3,016 $ 2,412 Americas 1,186 838 2,265 1,643 EMEA 497 479 950 882 Total $ 3,116 $ 2,623 $ 6,231 $ 4,937 _________________________________ (1) Revenue is attributed to geography based on bill from locations.

Guarantees

Guarantees	6 Months Ended
	Dec. 31, 2021
Guarantees [Abstract]
Guarantees	Indemnification Obligations The Company from time to time enters into agreements with customers, suppliers, partners and others in the ordinary course of business that provide indemnification for certain matters including, but not limited to, intellectual property infringement claims, environmental claims and breach of agreement claims. The nature of the Company’s indemnification obligations prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay. Historically, the Company has not made any significant indemnification payments under such agreements and no amount has been accrued in the Company’s condensed consolidated financial statements with respect to these indemnification obligations. Product Warranty The Company estimates probable product warranty costs at the time revenue is recognized. The Company generally warrants its products for a period of 1 to 5 years. The Company uses estimated repair or replacement costs and uses statistical modeling to estimate product warranty return rates in order to determine its warranty obligation. Changes in the Company’s product warranty liability during the six months ended December 31, 2021 and January 1, 2021 were as follows: For the Six Months Ended (Dollars in millions) December 31, January 1, Balance, beginning of period $ 136 $ 151 Warranties issued 43 37 Repairs and replacements (43) (42) Changes in liability for pre-existing warranties, including expirations 8 (9) Balance, end of period $ 144 $ 137

Earnings Per Share

Earnings Per Share	6 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Basic earnings per share is computed by dividing income available to shareholders by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed by dividing income available to shareholders by the weighted-average number of shares outstanding during the period and the number of additional shares that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, unvested restricted share units and performance-based share units and shares to be purchased under the Company’s Employee Stock Purchase Plan. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in fair market value of the Company’s share price can result in a greater dilutive effect from potentially dilutive securities. The following table sets forth the computation of basic and diluted net income per share attributable to the shareholders of the Company: For the Three Months Ended For the Six Months Ended (In millions, except per share data) December 31, January 1, December 31, January 1, Numerator: Net income $ 501 $ 280 $ 1,027 $ 503 Number of shares used in per share calculations: Total shares for purposes of calculating basic net income per share 221 249 224 253 Weighted-average effect of dilutive securities: Employee equity award plans 4 2 4 2 Total shares for purpose of calculating diluted net income per share 225 251 228 255 Net income per share: Basic $ 2.27 $ 1.12 $ 4.58 $ 1.99 Diluted 2.23 1.12 4.50 1.97 The anti-dilutive shares related to employee equity award plans that were excluded from the computation of diluted net income per share were not material for the three and six months ended December 31, 2021 and January 1, 2021.

Legal, Environmental and Other

Legal, Environmental and Other Contingencies	6 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Legal, Environmental and Other Contingencies	The Company assesses the probability of an unfavorable outcome of all its material litigation, claims or assessments to determine whether a liability had been incurred and whether it is probable that one or more future events will occur confirming the fact of the loss. In the event that an unfavorable outcome is determined to be probable and the amount of the loss can be reasonably estimated, the Company establishes an accrual for the litigation, claim or assessment. In addition, in the event an unfavorable outcome is determined to be less than probable, but reasonably possible, the Company will disclose an estimate of the possible loss or range of such loss; however, when a reasonable estimate cannot be made, the Company will provide disclosure to that effect. Litigation is inherently uncertain and may result in adverse rulings or decisions. Additionally, the Company may enter into settlements or be subject to judgments that may, individually, or in the aggregate, have a material adverse effect on its results of operations. Accordingly, actual results could differ materially. Litigation Lambeth Magnetic Structures LLC v. Seagate Technology (US) Holdings, Inc., et al. On April 29, 2016, Lambeth Magnetic Structures LLC filed a complaint against Seagate Technology (US) Holdings, Inc. and Seagate Technology LLC in the U.S. District Court for the Western District of Pennsylvania, alleging infringement of U.S. Patent No. 7,128,988, “Magnetic Material Structures, Devices and Methods.” The complaint seeks damages as well as additional relief. The Company believes the claims asserted in the complaint are without merit and intends to vigorously defend this case. The court issued its claim construction ruling on October 18, 2017. The trial is scheduled to begin on April 4, 2022. While the possible range of loss for this matter remains uncertain, the Company estimates the amount of loss to be immaterial to the financial statements. Seagate Technology LLC, et al. v. NHK Spring Co. Ltd. and TDK Corporation, et al . On February 18, 2020, Seagate Technology LLC, Seagate Technology (Thailand) Ltd., Seagate Singapore International Headquarters Pte. Ltd., and Seagate Technology International filed a complaint in the United States District Court for the Northern District of California against defendant suppliers of HDD suspension assemblies. Defendants include NHK Spring Co. Ltd., TDK Corporation, Hutchinson Technology Inc., and several of their subsidiaries and affiliates. The complaint includes federal and state antitrust law claims, as well as a breach of contract claim. The complaint alleges that defendants and their co-conspirators knowingly conspired for more than twelve years not to compete in the supply of suspension assemblies; that defendants misused confidential information that the Company had provided pursuant to nondisclosure agreements, in breach of their contractual obligations; and that the Company paid artificially high prices on its purchases of suspension assemblies. The Company seeks to recover the overcharges it paid for suspension assemblies, as well as additional relief permitted by law. Nidec Corporation v. Seagate Technology LLC, et al. On January 18, 2021, Nidec Corporation (“Nidec”) filed a complaint against Seagate Technology LLC, Seagate Singapore International Headquarters Pte. Ltd., and Seagate Technology (Netherlands) B.V. in the United States District Court for the District of Delaware, alleging infringement of the following patents: U.S. Patent No. 8,737,017, titled “Spindle Motor and Disk Drive Apparatus,” U.S. Patent No. 9,742,239, titled “Spindle Motor and Disk Drive Apparatus,” U.S. Patent No. 9,935,528, titled “Spindle Motor and Disk Drive Apparatus,” U.S. Patent No. 10,407,775, titled “Base Plate, Hard Disk Drive, and Method of Manufacturing Base Plate,” and U.S. Patent No. 10,460,767, titled “Base Member Including Information Mark and Insulating Coating Layer, and Disk Drive Apparatus Including the Same.” (the “Delaware Action”). On March 22, 2021, Seagate initiated JAMS arbitration against Nidec under the arbitration clause of the covenant agreement between Seagate and Nidec. On July 20, 2021, the court stayed the Delaware Action pending the result of arbitration between the parties. On November 9, 2021, following a five-day arbitration hearing, the JAMS arbitration panel decided in favor of Seagate on all issues and directed Nidec to dismiss the Delaware Action. On November 15, 2021, Nidec dismissed its complaint in the Delaware Action with prejudice. Environmental Matters The Company’s operations are subject to U.S. and foreign laws and regulations relating to the protection of the environment, including those governing discharges of pollutants into the air and water, the management and disposal of hazardous substances and wastes and the cleanup of contaminated sites. Some of the Company’s operations require environmental permits and controls to prevent and reduce air and water pollution, and these permits are subject to modification, renewal and revocation by issuing authorities. The Company has established environmental management systems and continually updates its environmental policies and standard operating procedures for its operations worldwide. The Company believes that its operations are in material compliance with applicable environmental laws, regulations and permits. The Company budgets for operating and capital costs on an ongoing basis to comply with environmental laws. If additional or more stringent requirements are imposed on the Company in the future, it could incur additional operating costs and capital expenditures. Some environmental laws, such as the Comprehensive Environmental Response Compensation and Liability Act of 1980 (as amended, the “Superfund” law) and its state equivalents, can impose liability for the cost of cleanup of contaminated sites upon any of the current or former site owners or operators or upon parties who sent waste to these sites, regardless of whether the owner or operator owned the site at the time of the release of hazardous substances or the lawfulness of the original disposal activity. The Company has been identified as a responsible or potentially responsible party at several sites. At each of these sites, the Company has an assigned portion of the financial liability based on the type and amount of hazardous substances disposed of by each party at the site and the number of financially viable parties. The Company has fulfilled its responsibilities at some of these sites and remains involved in only a few at this time. While the Company’s ultimate costs in connection with these sites is difficult to predict with complete accuracy, based on its current estimates of cleanup costs and its expected allocation of these costs, the Company does not expect costs in connection with these sites to be material. The Company may be subject to various state, federal and international laws and regulations governing the environment, including those restricting the presence of certain substances in electronic products. For example, the European Union (“EU”) enacted the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU), which prohibits the use of certain substances, including lead, in certain products, including disk drives and server storage products, put on the market after July 1, 2006. Similar legislation has been or may be enacted in other jurisdictions, including in the U.S., Canada, Mexico, Taiwan, China, Japan and others. The EU REACH Directive (Registration, Evaluation, Authorization, and Restriction of Chemicals, EC 1907/2006) also restricts substances of very high concern in products. If the Company or its suppliers fails to comply with the substance restrictions, recycle requirements or other environmental requirements as they are enacted worldwide, it could have a materially adverse effect on the Company’s business. Other Matters The Company is involved in a number of other judicial, regulatory or administrative proceedings and investigations incidental to its business, and the Company may be involved in such proceedings and investigations arising in the normal course of its business in the future. Although occasional adverse decisions or settlements may occur, the Company believes that the final disposition of such matters will not have a material adverse effect on its financial position or results of operations.

Commitments

Commitments	6 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments	Commitments Unconditional Long-Term Purchase Obligations. As of December 31, 2021, the Company had unconditional long-term purchase obligations of approximately $495 million, primarily related to purchases of minimum quarterly amounts of inventory components. The Company expects the commitment to total $259 million, $162 million, $33 million, $26 million and $15 million for fiscal years 2023, 2024, 2025, 2026 and thereafter, respectively.

Subsequent event

Subsequent event	6 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Dividend Declared O n January 26, 2022, the Com pany’s Board of Directors declared a quarterly cash dividend of $0.70 per share, which will be payable on April 6, 2022 to shareholders of record as of the close of business on March 22, 2022 .

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Consolidation, Policy	The Company’s consolidated financial statements for the fiscal year ended July 2, 2021 are included in its Annual Report on Form 10-K, as filed with the U.S. Securities and Exchange Commission (“SEC”) on August 6, 2021. The Company believes that the disclosures included in these unaudited condensed consolidated financial statements, when read in conjunction with its consolidated financial statements as of July 2, 2021, and the notes thereto, are adequate to make the information presented not misleading. The results of operations and the cash flows for the three and six months ended December 31, 2021 are not necessarily indicative of the results to be expected for any subsequent interim period or for the Company’s fiscal year ending July 1, 2022.
Fiscal Period, Policy	The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. In fiscal years with 53 weeks, the first quarter consists of 14 weeks and the remaining quarters consist of 13 weeks each. The three and six months ended December 31, 2021 consisted of 13 and 26 weeks, respectively, and the three and six months ended January 1, 2021 consisted of 13 and 26 weeks, respectively. Fiscal year 2022, which ends on July 1, 2022, is comprised of 52 weeks and fiscal year 2021, which ended on July 2, 2021, was comprised of 52 weeks. The fiscal quarters ended December 31, 2021, October 1, 2021 and January 1, 2021, are also referred to herein as the “December 2021 quarter”, the “September 2021 quarter” and the “December 2020 quarter”, respectively.
Recently Issued Accounting Pronouncements, Policy	Recently Adopted Accounting Pronouncements In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12 (ASC Topic 740), Simplifying the Accounting for Income Taxes. This ASU simplifies accounting for income taxes by removing certain exceptions to the general principles and amending existing guidance to improve consistent application. This ASU became effective and the Company adopted the guidance in the September 2021 quarter. The adoption of this ASU did not have an impact on the Company’s condensed consolidated financial statements. In July 2021, the FASB issued ASU 2021-05 (ASC Topic 842), Lessors—Certain Leases with Variable Lease Payments. This ASU requires lessors to classify and account for a lease with variable lease payments that do not depend on a reference index or a rate as an operating lease if the lease would have been classified as a sales-type lease or a direct financing lease and the lessor would have otherwise recognized a day-one loss. The Company adopted the guidance in the September 2021 quarter on a prospective basis. The adoption of this ASU did not have an impact on the Company’s condensed consolidated financial statements. Recently Issued Accounting Pronouncements In March 2020, the FASB issued ASU 2020-04 (ASC Topic 848), Reference Rate Reform. This ASU provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. Adoption of the expedients and exceptions is permitted upon issuance of this update through December 31, 2022. The Company does not expect the adoption of this ASU to have a material impact on its condensed consolidated financial statements. In November 2021, the FASB issued ASU 2021-10 (ASC Topic 832), Disclosures by Business Entities about Government Assistance . This ASU requires annual disclosures that increase the transparency of transactions involving government grants, including (1) the type of transactions, (2) the accounting for those transactions and (3) the effect of those transactions on an entity’s financial statements. The Company is required to adopt this new accounting pronouncement in the first quarter of fiscal year 2023. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its condensed consolidated financial statements.
Derivatives, Policy	The Company is exposed to foreign currency exchange rate, interest rate, and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. As of December 31, 2021, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.2 billion, of which $600 million will mature in September 2025 and $600 million will mature in July 2027.
Fair Value Measurement, Policy	Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company’s own assumptions of market participant valuation (unobservable inputs). A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 — Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 — Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 — Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively.
Fair Value of Financial Instruments, Policy	Items Measured at Fair Value on a Non-Recurring Basis From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under the equity method or the measurement alternative. If measured at fair value in the Condensed Consolidated Balance Sheets, these investments would generally be classified in Level 3 of the fair value hierarchy. For the investments that are accounted for under the equity method, the Company recorded an immaterial gain and a net gain of $3 million for the three and six months ended December 31, 2021, respectively. The Company recorded a net gain of $1 million and an immaterial gain for the three and six months ended January 1, 2021, respectively. The adjusted carrying value of the investments accounted for under the equity method amounted to $81 million and $78 million as of December 31, 2021 and July 2, 2021, respectively. For the investments that are accounted for under the measurement alternative, the Company recorded a net loss of $2 million and a net gain of $4 million for the three and six months ended December 31, 2021, respectively. The Company recorded a net loss of $7 million and a net gain of $16 million for the three and six months ended January 1, 2021, respectively, related to downward and upward adjustments due to observable price changes. As of December 31, 2021 and July 2, 2021, the carrying value of the Company’s strategic investments under the measurement alternative was $88 million and $117 million, respectively.
Standard Product Warranty, Policy	Product WarrantyThe Company estimates probable product warranty costs at the time revenue is recognized. The Company generally warrants its products for a period of 1 to 5 years. The Company uses estimated repair or replacement costs and uses statistical modeling to estimate product warranty return rates in order to determine its warranty obligation.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Policies)	6 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives, Policy	The Company is exposed to foreign currency exchange rate, interest rate, and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. As of December 31, 2021, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.2 billion, of which $600 million will mature in September 2025 and $600 million will mature in July 2027.

Fair Value Measures and Disclos

Fair Value Measures and Disclosures (Policies)	6 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments, Policy	Items Measured at Fair Value on a Non-Recurring Basis From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under the equity method or the measurement alternative. If measured at fair value in the Condensed Consolidated Balance Sheets, these investments would generally be classified in Level 3 of the fair value hierarchy. For the investments that are accounted for under the equity method, the Company recorded an immaterial gain and a net gain of $3 million for the three and six months ended December 31, 2021, respectively. The Company recorded a net gain of $1 million and an immaterial gain for the three and six months ended January 1, 2021, respectively. The adjusted carrying value of the investments accounted for under the equity method amounted to $81 million and $78 million as of December 31, 2021 and July 2, 2021, respectively. For the investments that are accounted for under the measurement alternative, the Company recorded a net loss of $2 million and a net gain of $4 million for the three and six months ended December 31, 2021, respectively. The Company recorded a net loss of $7 million and a net gain of $16 million for the three and six months ended January 1, 2021, respectively, related to downward and upward adjustments due to observable price changes. As of December 31, 2021 and July 2, 2021, the carrying value of the Company’s strategic investments under the measurement alternative was $88 million and $117 million, respectively.
Fair Value Measurement, Policy	Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company’s own assumptions of market participant valuation (unobservable inputs). A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 — Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 — Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 — Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively.

Balance Sheet Information (Tabl

Balance Sheet Information (Tables)	6 Months Ended
	Dec. 31, 2021
Disclosure Text Block Supplement [Abstract]
Summary of Debt Securities, Available-for-sale	The following table summarizes, by major type, the fair value and amortized cost of the Company’s available-for-sale debt investments as of December 31, 2021 and July 2, 2021: December 31, July 2, (Dollars in millions) Amortized Cost Unrealized Gain/(Loss) Fair Value Amortized Cost Unrealized Gain/(Loss) Fair Value Available-for-sale debt securities: Money market funds $ 435 $ — $ 435 $ 552 $ — $ 552 Time deposits and certificates of deposit 1 — 1 1 — 1 Other debt securities 36 — 36 18 — 18 Total $ 472 $ — $ 472 $ 571 $ — $ 571 Included in Cash and cash equivalents $ 434 $ 551 Included in Other current assets 2 2 Included in Other assets, net 36 18 Total $ 472 $ 571
Fair value and amortized cost of available-for-sale securities by contractual maturity	The fair value and amortized cost of the Company’s investments classified as available-for-sale debt securities as of December 31, 2021, by remaining contractual maturity were as follows: (Dollars in millions) Amortized Cost Fair Value Due in less than 1 year $ 436 $ 436 Due in 1 to 5 years 28 28 Due in 6 to 10 years — — Thereafter 8 8 Total $ 472 $ 472
Cash, cash equivalents, and restricted cash	The following table provides a summary of cash, cash equivalents and restricted cash reported within the Company’s Condensed Consolidated Balance Sheets that reconciles to the corresponding amount in the Company’s Condensed Consolidated Statements of Cash Flows: (Dollars in millions) December 31, July 2, January 1, July 3, Cash and cash equivalents $ 1,535 $ 1,209 $ 1,799 $ 1,722 Restricted cash included in Other current assets 2 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 1,537 $ 1,211 $ 1,801 $ 1,724
Inventories	The following table provides details of the inventory balance sheet item: (Dollars in millions) December 31, July 2, Raw materials and components $ 474 $ 375 Work-in-process 463 443 Finished goods 350 386 Total inventories $ 1,287 $ 1,204
Property, Equipment and Leasehold Improvements, net	The components of property, equipment and leasehold improvements, net, were as follows: (Dollars in millions) December 31, July 2, Property, equipment and leasehold improvements $ 10,521 $ 10,378 Accumulated depreciation and amortization (8,305) (8,197) Property, equipment and leasehold improvements, net $ 2,216 $ 2,181
Accrued expenses	The following table provides details of the accrued expenses balance sheet item: (Dollars in millions) December 31, July 2, Dividends payable $ 154 $ 153 Other accrued expenses 501 455 Total $ 655 $ 608
Schedule of accumulated other comprehensive income (loss)	The components of AOCL, net of tax, were as follows: (Dollars in millions) Unrealized Gains/(Losses) on Cash Flow Hedges Unrealized Gains/(Losses) on Post-Retirement Plans Foreign Currency Translation Adjustments Total Balance at July 2, 2021 $ (18) $ (22) $ (1) $ (41) Other comprehensive income before reclassifications 2 1 — 3 Amounts reclassified from AOCL 12 1 — 13 Other comprehensive income 14 2 — 16 Balance at December 31, 2021 $ (4) $ (20) $ (1) $ (25) Balance at July 3, 2020 $ (24) $ (26) $ (16) $ (66) Other comprehensive income (loss) before reclassifications 16 (1) — 15 Amounts reclassified from AOCL (2) 2 15 15 Other comprehensive income 14 1 15 30 Balance at January 1, 2021 $ (10) $ (25) $ (1) $ (36)

Debt (Tables)

Debt (Tables)	6 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Future principal payments on long-term debt	At December 31, 2021, future principal payments on long-term debt were as follows (in millions): Fiscal Year Amount Remainder of 2022 $ 220 2023 585 2024 560 2025 562 2026 563 Thereafter 3,445 Total $ 5,935

Restructuring and Exit Costs Re

Restructuring and Exit Costs Restructuring and Exit Costs (Tables)	6 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	The following tables summarize the Company’s restructuring activities under the Company’s active restructuring plans: (Dollars in millions) Workforce Reduction Costs Facilities and Other Exit Costs Total Accrual balances at July 2, 2021 $ 2 $ 6 $ 8 Restructuring charges 2 — 2 Cash payments (2) (2) (4) Accrual balances at December 31, 2021 $ 2 $ 4 $ 6 Total costs incurred inception to date as of December 31, 2021 $ 65 $ 23 $ 88 Total expected charges to be incurred as of December 31, 2021 $ — $ 8 $ 8

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of notional value of outstanding foreign currency forward exchange contracts	The following tables show the total notional value of the Company’s outstanding foreign currency forward exchange contracts as of December 31, 2021 and July 2, 2021. All of the foreign currency forward exchange contracts mature within 12 months. As of December 31, 2021 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 170 $ 54 Thai Baht 130 42 Chinese Renminbi 84 22 British Pound Sterling 65 18 $ 449 $ 136 As of July 2, 2021 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 172 $ 43 Thai Baht 131 46 Chinese Renminbi 73 21 British Pound Sterling 54 16 $ 430 $ 126
Schedule of gross fair value of derivative instruments	The following tables show the Company’s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of December 31, 2021 and July 2, 2021: As of December 31, 2021 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Location Fair Value Balance Sheet Location Fair Value Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ 1 Accrued expenses $ (2) Interest rate swap Other current assets 2 Accrued expenses (5) Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets 1 Accrued expenses (3) Total derivatives $ 4 $ (10) As of July 2, 2021 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Location Fair Value Balance Sheet Location Fair Value Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ 1 Accrued expenses $ (5) Interest rate swap Other current assets — Accrued expenses (14) Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets 1 Accrued expenses (2) Total return swap Other current assets 2 Accrued expenses — Total derivatives $ 4 $ (21)
Schedule of the effect of derivative instruments on Other comprehensive income (loss) and the Consolidated Statement of Operations	The following tables show the effect of the Company’s derivative instruments on the Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Operations for the three and six months ended December 31, 2021: Amount of Gain/(Loss) Recognized in Income on Derivatives (Dollars in millions) Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Income on Derivatives For the Three Months For the Six Months Foreign currency forward exchange contracts Other, net $ 2 $ (2) Total return swap Operating expenses 7 6 The following tables show the effect of the Company’s derivative instruments on the Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Operations for the three and six months ended January 1, 2021 : (Dollars in millions) Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Income on Derivatives Amount of Gain/(Loss) Recognized in Income on Derivatives For the Three Months For the Six Months Foreign currency forward exchange contracts Other, net $ 6 $ 14 Total return swap Operating expenses $ 11 $ 16

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	December 31, 2021 July 2, 2021 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (Dollars in millions) Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Assets: Money market funds $ 434 $ — $ — $ 434 $ 551 $ — $ — $ 551 Total cash equivalents 434 — — 434 551 — — 551 Restricted cash and investments: Money market funds 1 — — 1 1 — — 1 Time deposits and certificates of deposit — 1 — 1 — 1 — 1 Other debt securities — — 36 36 — — 18 18 Derivative assets — 4 — 4 — 4 — 4 Total assets $ 435 $ 5 $ 36 $ 476 $ 552 $ 5 $ 18 $ 575 Liabilities: Derivative liabilities $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21 Total liabilities $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21
Schedule of Fair Value, by Balance Sheet Grouping, Measured on Recurring Basis	December 31, 2021 July 2, 2021 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (Dollars in millions) Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Quoted Prices in Active Markets for Identical Instruments (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Total Balance Assets: Cash and cash equivalents $ 434 $ — $ — $ 434 $ 551 $ — $ — $ 551 Other current assets 1 5 — 6 1 5 — 6 Other assets, net — — 36 36 — — 18 18 Total assets $ 435 $ 5 $ 36 $ 476 $ 552 $ 5 $ 18 $ 575 Liabilities: Accrued expenses $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21 Total liabilities $ — $ 10 $ — $ 10 $ — $ 21 $ — $ 21

Equity (Tables)

Equity (Tables)	6 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Schedule of Share Repurchases	The following table sets forth information with respect to repurchases of ordinary shares during the six months ended December 31, 2021: (In millions) Number of Shares Repurchased Dollar Value of Shares Repurchased Repurchases of ordinary shares (1) 10 $ 905 Tax withholding related to vesting of equity awards 1 45 Total 11 $ 950

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table provides information about disaggregated revenue by sales channel and geographical region for the Company’s single reportable segment: For the Three Months Ended For the Six Months Ended (Dollars in millions) December 31, January 1, December 31, January 1, Revenues by Channel OEMs $ 2,178 $ 1,741 $ 4,465 $ 3,349 Distributors 562 475 1,069 842 Retailers 376 407 697 746 Total $ 3,116 $ 2,623 $ 6,231 $ 4,937 Revenues by Geography (1) Asia Pacific $ 1,433 $ 1,306 $ 3,016 $ 2,412 Americas 1,186 838 2,265 1,643 EMEA 497 479 950 882 Total $ 3,116 $ 2,623 $ 6,231 $ 4,937 _________________________________ (1) Revenue is attributed to geography based on bill from locations.

Guarantees (Tables)

Guarantees (Tables)	6 Months Ended
	Dec. 31, 2021
Guarantees [Abstract]
Schedule of Product Warranty Liability	Changes in the Company’s product warranty liability during the six months ended December 31, 2021 and January 1, 2021 were as follows: For the Six Months Ended (Dollars in millions) December 31, January 1, Balance, beginning of period $ 136 $ 151 Warranties issued 43 37 Repairs and replacements (43) (42) Changes in liability for pre-existing warranties, including expirations 8 (9) Balance, end of period $ 144 $ 137

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted net income (loss) per share	The following table sets forth the computation of basic and diluted net income per share attributable to the shareholders of the Company: For the Three Months Ended For the Six Months Ended (In millions, except per share data) December 31, January 1, December 31, January 1, Numerator: Net income $ 501 $ 280 $ 1,027 $ 503 Number of shares used in per share calculations: Total shares for purposes of calculating basic net income per share 221 249 224 253 Weighted-average effect of dilutive securities: Employee equity award plans 4 2 4 2 Total shares for purpose of calculating diluted net income per share 225 251 228 255 Net income per share: Basic $ 2.27 $ 1.12 $ 4.58 $ 1.99 Diluted 2.23 1.12 4.50 1.97

Balance Sheet Information (Summ

Balance Sheet Information (Summary of fair value and amortized cost of investments, by major type) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Available-for-sale debt securities:
Amortized Cost	$ 472	$ 571
Unrealized Gain/(Loss)	0	0
Fair Value	472	571
Cash and cash equivalents [Member]
Available-for-sale debt securities:
Fair Value	434	551
Other current assets [Member]
Available-for-sale debt securities:
Fair Value	36	2
Other Assets [Member]
Available-for-sale debt securities:
Fair Value	2	18
Money market funds [Member]
Available-for-sale debt securities:
Amortized Cost	435	552
Unrealized Gain/(Loss)	0	0
Fair Value	435	552
Time deposits and certificates of deposit [Member]
Available-for-sale debt securities:
Amortized Cost	1	1
Unrealized Gain/(Loss)	0	0
Fair Value	1	1
Other debt securities
Available-for-sale debt securities:
Amortized Cost	36	18
Unrealized Gain/(Loss)	0	0
Fair Value	$ 36	$ 18

Balance Sheet Information Balan

Balance Sheet Information Balance Sheet Information (Available-for-Sale Debt Securities) (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Dec. 31, 2021	Jul. 02, 2021	Jan. 01, 2021	Jul. 03, 2020
Investments, Debt and Equity Securities [Abstract]
Restricted cash included in Other current assets	$ 2	$ 2	$ 2	$ 2
Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale	$ 0	$ 0

Balance Sheet Information (Fair

Balance Sheet Information (Fair value and amortized cost of available-for-sale securities by contractual maturity) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Schedule of Held-to-maturity Securities [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	$ 472	$ 571
Unrealized Gain/(Loss)	0	0
Fair Value	472	571
Amortized Cost
Amortized cost, due in less than 1 year	436
Amortized cost, due in 1 to 5 years	28
Amortized cost, due in 6 to 10 years	0
Amortized cost, thereafter	8
Amortized Cost	472
Fair Value
Fair value, due in less than 1 year	436
Fair value, due in 1 to 5 years	28
Fair value, due in 6 to 10 years	0
Fair value, thereafter	8
Fair Value	472
Money market funds [Member]
Schedule of Held-to-maturity Securities [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	435	552
Unrealized Gain/(Loss)	0	0
Fair Value	435	552
Time deposits and certificates of deposit [Member]
Schedule of Held-to-maturity Securities [Line Items]
Debt Securities, Available-for-sale, Amortized Cost	1	1
Unrealized Gain/(Loss)	0	0
Fair Value	1	1
Cash and cash equivalents [Member]
Schedule of Held-to-maturity Securities [Line Items]
Fair Value	434	551
Other current assets [Member]
Schedule of Held-to-maturity Securities [Line Items]
Fair Value	36	2
Other Assets [Member]
Schedule of Held-to-maturity Securities [Line Items]
Fair Value	$ 2	$ 18

Balance Sheet Information (Cash

Balance Sheet Information (Cash, Cash Equivalents, and Restricted Cash) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021	Jan. 01, 2021	Jul. 03, 2020
Investments, Debt and Equity Securities [Abstract]
Cash and cash equivalents	$ 1,535	$ 1,209	$ 1,799	$ 1,722
Restricted cash included in Other current assets	2	2	2	2
Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows	$ 1,537	$ 1,211	$ 1,801	$ 1,724

Balance Sheet Information (Inve

Balance Sheet Information (Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Inventory, Net [Abstract]
Raw materials and components	$ 474	$ 375
Work-in-process	463	443
Finished goods	350	386
Total inventories	$ 1,287	$ 1,204

Balance Sheet Information (Prop

Balance Sheet Information (Property, Equipment and Leasehold Improvements, net) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Property, Plant and Equipment, Net [Abstract]
Property, equipment and leasehold improvements	$ 10,521	$ 10,378
Accumulated depreciation and amortization	(8,305)	(8,197)
Property, equipment and leasehold improvements, net	$ 2,216	$ 2,181

Balance Sheet Information (Accr

Balance Sheet Information (Accrued expenses) (Details) - USD ($)	Dec. 31, 2021	Jul. 02, 2021
Payables and Accruals [Abstract]
Dividends payable	$ 154,000,000	$ 153,000,000
Other accrued expenses	501,000,000	455,000,000
Total	$ 655,000,000	$ 608,000,000

Balance Sheet Information (AOCI

Balance Sheet Information (AOCI) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Net unrealized (losses) gains arising during the period	$ 11	$ 12	$ 2	$ 16
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax	0	(1)		(1)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	601	1,821	631	1,787
Losses (gains) reclassified into earnings	9	(2)	12	(2)
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax	0	1		2
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	0	0	(2)	(1)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	0	0	0	15
Other comprehensive income	20	10	16	30
Ending balance	526	990	526	990
Accumulated Other Comprehensive Loss [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(45)	(46)	(41)	(66)
Other comprehensive (loss) income before reclassifications			3	15
Amounts reclassified from AOCL			13	15
Other comprehensive income			16	30
Ending balance	(25)	(36)	(25)	(36)
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(18)	(24)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax			14	14
Ending balance	(4)	(10)	(4)	(10)
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax			1
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(22)	(26)
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax			1
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax			2	1
Ending balance	(20)	(25)	(20)	(25)
Foreign currency translation adjustments [Member]
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(1)	(16)
Other comprehensive (loss) income before reclassifications				0
Amounts reclassified from AOCL				15
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax			0	15
Ending balance	$ (1)	$ (1)	$ (1)	$ (1)

Debt (Narrative) (Details)

Debt (Narrative) (Details) - USD ($)

Oct. 14, 2021

Sep. 17, 2019

Dec. 31, 2021

Dec. 31, 2021

Jan. 01, 2021

Jul. 02, 2021

Jan. 13, 2021

Dec. 08, 2020

Jun. 18, 2020

Jun. 10, 2020

Sep. 18, 2019

Feb. 20, 2019

Feb. 03, 2017

May 14, 2015

Dec. 02, 2014

May 28, 2014

May 22, 2013

Debt Instrument [Line Items]

Amount of borrowings drawn

$ 0

Repayments of Long-term Debt

$ 481,000,000

$ 21,000,000

Less: current portion of debt

(235,000,000)

(235,000,000)

$ (245,000,000)

Long-term Debt, Excluding Current Maturities

5,626,000,000

5,626,000,000

4,894,000,000

Reported Value Measurement [Member]

Debt Instrument [Line Items]

Long-term debt, gross

5,895,000,000

5,895,000,000

5,173,000,000

Debt issuance costs

(34,000,000)

(34,000,000)

(34,000,000)

Debt, net of debt issuance costs

5,861,000,000

5,861,000,000

5,139,000,000

Less: current portion of debt

(235,000,000)

(235,000,000)

(245,000,000)

Long-term Debt, Excluding Current Maturities

5,626,000,000

5,626,000,000

4,894,000,000

Senior Notes 4.25 Percent Due March 2022 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

220,000,000

220,000,000

220,000,000

Senior Notes 4.75 Percent Due June 2023 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

541,000,000

541,000,000

541,000,000

Senior Notes 4.875 Percent Due March 2024 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

499,000,000

499,000,000

499,000,000

Senior Notes 4.75 Percent Due January 2025 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

479,000,000

479,000,000

479,000,000

Senior Notes 4.875 percent Due June 2027 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

504,000,000

504,000,000

504,000,000

Senior note 5.75 percent due December 2034 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

489,000,000

489,000,000

489,000,000

Senior note 4.091 percent due June 2029 | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

463,000,000

463,000,000

461,000,000

Senior note 5.75 percent due December 2034 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

500,000,000

500,000,000

499,000,000

Senior note 3.125 percent due July 2029 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

500,000,000

500,000,000

500,000,000

Senior Notes 3.375 Percent due July 2031 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

500,000,000

500,000,000

500,000,000

LIBOR based Term Loan Due September 2025 [Member] | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

0

0

$ 481,000,000

Term Loan A1 | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

600,000,000

600,000,000

Term Loan A2 | Reported Value Measurement [Member]

Debt Instrument [Line Items]

Senior Notes

$ 600,000,000

$ 600,000,000

2019 Revolving Credit Facility | Revolving Credit Facility

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 1,750,000,000

$ 1,725,000,000

Term Loan | Revolving Credit Facility

Debt Instrument [Line Items]

Redemption price

1.25%

Term Loan | Term Loan

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 500,000,000

Amount of borrowings drawn

$ 500,000,000

Line of Credit Facility, Repayment

475,000,000

Senior Notes | Senior Notes 4.25 Percent Due March 2022 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 750,000,000

Stated interest rate (as a percent)

4.25%

Amount of debt repurchased

$ 9,000,000

Senior Notes | Senior Notes 4.75 Percent Due June 2023 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Amount of debt repurchased

$ 5,000,000

Gain (loss) on repurchase of debt instrument

$ 1,000,000

Senior Notes | Senior Notes 4.875 Percent Due March 2024 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | Senior Notes 4.75 Percent Due January 2025 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | Senior Notes 4.875 percent Due June 2027 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 700,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | Senior note 5.75 percent due December 2034 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

5.75%

Senior Notes | Senior note 4.091 percent due June 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.091%

Senior Notes | Senior note 5.75 percent due December 2034 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.125%

Senior Notes | Senior note 3.125 percent due July 2029 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

3.125%

Senior Notes | Senior Notes 3.375 Percent due July 2031 [Member]

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

3.375%

Term Loan A1 | Term Loan

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

600,000,000

Term Loan A2 | Term Loan

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

600,000,000

October 2021 Term Loan | Term Loan

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

1,200,000,000

October 2021 Term Loan A2 | Term Loan

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Minimum | 2019 Revolving Credit Facility

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

1.125%

Minimum | Term Loan A1

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

1.125%

Minimum | Term Loan A2

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

1.25%

Maximum | 2019 Revolving Credit Facility

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.375%

Maximum | Term Loan A1

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.375%

Maximum | Term Loan A2

Debt Instrument [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.50%

Debt (Future principal payments

Debt (Future principal payments on long-term debt) (Details) $ in Millions	Dec. 31, 2021USD ($)
Debt Disclosure [Abstract]
Repayments of long-term debt, remainder of 2021	$ 220
Repayments of long-term debt, 2022	585
Repayments of long-term debt, 2023	560
Repayments of long-term debt, 2024	562
Repayments of long-term debt, 2025	563
Thereafter	3,445
Total future principal payments on long-term debt	$ 5,935

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 13	$ 11	$ 20	$ 9
Net discrete tax expense			(9)	$ (11)
Unrecognized Tax Benefits	$ 115		$ 115
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	25.00%	25.00%	25.00%	25.00%
Unrecognized tax benefits, period increase (decrease)			$ 7

Restructuring and Exit Costs (D

Restructuring and Exit Costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Restructuring Reserve [Roll Forward]
Restructuring and other, net	$ 1	$ 2	$ 2	$ 3
Employee severance [Member] | Other Restructuring Plans [Member]
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning balance			2
Restructuring charges			2
Cash payments			(2)
Restructuring accrual, ending balance	2		2
Total costs incurred inception to date as of December 31, 2021			65
Total expected charges to be incurred as of December 31, 2021	0		0
Facility closing [Member] | Other Restructuring Plans [Member]
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning balance			6
Restructuring charges			0
Cash payments			(2)
Restructuring accrual, ending balance	4		4
Total costs incurred inception to date as of December 31, 2021			23
Total expected charges to be incurred as of December 31, 2021	8		8
Restructuring Charges [Member]
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning balance			8
Restructuring charges			2
Cash payments			(4)
Restructuring accrual, ending balance	6		6
Total costs incurred inception to date as of December 31, 2021			88
Total expected charges to be incurred as of December 31, 2021	$ 8		$ 8

Derivative Financial Instrume_3

Derivative Financial Instruments Derivative Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021	Jul. 02, 2021
Term Loan
Derivative Financial Instruments
Derivative, notional amount	$ 1,200		$ 1,200
Term Loan A1
Derivative Financial Instruments
Derivative, notional amount	600		600
Cash Flow Hedging [Member]
Derivative Financial Instruments
Unrealized Gain (Loss) on Cash Flow Hedging Instruments			(4)		$ (18)
Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	10		10
Derivative Instruments, Gain Reclassified from Accumulated OCI into Income, Effective Portion		$ 4		$ 4
Cash Flow Hedging [Member] | Other Nonoperating Income (Expense) [Member]
Derivative Financial Instruments
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion		$ (2)		$ (4)
Cash Flow Hedging [Member] | Cost of Sales [Member]
Derivative Financial Instruments
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion	(6)		(8)
Cash Flow Hedging [Member] | Interest Expense
Derivative Financial Instruments
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion	(3)		(4)
Derivatives not designated as hedging instruments [Member] | Total Return Swap [Member]
Derivative Financial Instruments
Derivative, notional amount	$ 133		$ 133

Derivative Financial Instrume_4

Derivative Financial Instruments (Schedule of the effect of derivative instruments on Other comprehensive income (loss) and the Consolidated Statement of Operations) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Foreign currency forward exchange contracts [Member] | Other Nonoperating Income (Expense) [Member]
Derivatives Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Income on Derivatives	$ 2	$ 6	$ (2)	$ 14
Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion)	4	11	(5)	15
Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	(6)	4	(8)	4
Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	1	1	1
Interest Rate Swap | Other Nonoperating Income (Expense) [Member]
Derivatives Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion)	7	1	7	1
Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	(3)	(2)	(4)	(4)
Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0	0
Interest Rate Swap | Operating Expense [Member]
Derivatives Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Income on Derivatives		$ 11		$ 16
Total Return Swap [Member] | Operating Expense [Member]
Derivatives Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Income on Derivatives	$ 7		$ 6

Derivative Financial Instrume_5

Derivative Financial Instruments Derivative Financial Instruments (Schedule of notional value of outstanding foreign currency forward exchange contracts) (Details) - Foreign currency forward exchange contracts [Member] - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Designated as Hedging Instrument [Member]
Derivative Financial Instruments
Derivative, notional amount	$ 449	$ 430
Derivatives not designated as hedging instruments [Member]
Derivative Financial Instruments
Derivative, notional amount	136	126
Singapore, Dollars | Designated as Hedging Instrument [Member]
Derivative Financial Instruments
Derivative, notional amount	170	172
Singapore, Dollars | Derivatives not designated as hedging instruments [Member]
Derivative Financial Instruments
Derivative, notional amount	54	43
China, Yuan Renminbi | Designated as Hedging Instrument [Member]
Derivative Financial Instruments
Derivative, notional amount	84	73
China, Yuan Renminbi | Derivatives not designated as hedging instruments [Member]
Derivative Financial Instruments
Derivative, notional amount	22	21
United Kingdom, Pounds | Designated as Hedging Instrument [Member]
Derivative Financial Instruments
Derivative, notional amount	65	54
United Kingdom, Pounds | Derivatives not designated as hedging instruments [Member]
Derivative Financial Instruments
Derivative, notional amount	18	16
Thailand, Baht | Designated as Hedging Instrument [Member]
Derivative Financial Instruments
Derivative, notional amount	130	131
Thailand, Baht | Derivatives not designated as hedging instruments [Member]
Derivative Financial Instruments
Derivative, notional amount	$ 42	$ 46

Derivative Financial Instrume_6

Derivative Financial Instruments Derivative Financial Instruments (Schedule of gross fair value of derivative instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Derivatives, Fair Value [Line Items]
Derivative asset, fair value, gross asset	$ 4	$ 4
Derivative liability, fair value, gross liability	(10)	(21)
Foreign currency forward exchange contracts [Member] | Designated as Hedging Instrument [Member] | Other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value, gross asset	1	1
Foreign currency forward exchange contracts [Member] | Designated as Hedging Instrument [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value, gross liability	(2)	(5)
Foreign currency forward exchange contracts [Member] | Derivatives not designated as hedging instruments [Member] | Other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value, gross asset	1	1
Foreign currency forward exchange contracts [Member] | Derivatives not designated as hedging instruments [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value, gross liability	(3)	(2)
Interest Rate Swap | Designated as Hedging Instrument [Member] | Other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value, gross asset	2	0
Interest Rate Swap | Designated as Hedging Instrument [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value, gross liability	$ (5)	(14)
Total Return Swap [Member] | Derivatives not designated as hedging instruments [Member] | Other current assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value, gross asset		(2)
Total Return Swap [Member] | Derivatives not designated as hedging instruments [Member] | Accrued Expenses [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value, gross liability		$ 0

Fair Value (Schedule of Fair Va

Fair Value (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring basis [Member] - USD ($) $ in Thousands	Dec. 31, 2021	Jul. 02, 2021
Assets:
Total cash equivalents	$ 434,000	$ 551,000
Restricted cash and investments:
Total assets	476,000	575,000
Liabilities:
Total liabilities	10,000	(21,000)
Money market funds [Member]
Assets:
Total cash equivalents	434,000	551,000
Restricted cash and investments:
Restricted cash and investments:	1,000	1,000
Time deposits and certificates of deposit [Member]
Restricted cash and investments:
Restricted cash and investments:	1,000	1,000
Other debt securities
Restricted cash and investments:
Restricted cash and investments:	36,000	18,000
Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member]
Assets:
Total cash equivalents	434,000	551,000
Restricted cash and investments:
Total assets	435,000	552,000
Liabilities:
Total liabilities	0	0
Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member] | Money market funds [Member]
Assets:
Total cash equivalents	434,000	551,000
Restricted cash and investments:
Restricted cash and investments:	1,000	1,000
Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member] | Time deposits and certificates of deposit [Member]
Restricted cash and investments:
Restricted cash and investments:	0	0
Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member] | Other debt securities
Restricted cash and investments:
Restricted cash and investments:	0	0
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Total cash equivalents	0	0
Restricted cash and investments:
Total assets	5,000	5,000
Liabilities:
Total liabilities	10,000	(21,000)
Significant Other Observable Inputs (Level 2) [Member] | Money market funds [Member]
Assets:
Total cash equivalents	0	0
Restricted cash and investments:
Restricted cash and investments:	0	0
Significant Other Observable Inputs (Level 2) [Member] | Time deposits and certificates of deposit [Member]
Restricted cash and investments:
Restricted cash and investments:	1,000	1,000
Significant Other Observable Inputs (Level 2) [Member] | Other debt securities
Restricted cash and investments:
Restricted cash and investments:	0	0
Significant Unobservable Inputs (Level 3) [Member]
Assets:
Total cash equivalents	0	0
Restricted cash and investments:
Total assets	36,000	18,000
Liabilities:
Total liabilities	0	0
Significant Unobservable Inputs (Level 3) [Member] | Money market funds [Member]
Assets:
Total cash equivalents	0	0
Restricted cash and investments:
Restricted cash and investments:	0	0
Significant Unobservable Inputs (Level 3) [Member] | Time deposits and certificates of deposit [Member]
Restricted cash and investments:
Restricted cash and investments:	0	0
Significant Unobservable Inputs (Level 3) [Member] | Other debt securities
Restricted cash and investments:
Restricted cash and investments:	36,000	18,000
Derivative Financial Instruments, Assets [Member]
Restricted cash and investments:
Derivative assets	4,000	4,000
Derivative Financial Instruments, Assets [Member] | Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member]
Restricted cash and investments:
Derivative assets	0	0
Derivative Financial Instruments, Assets [Member] | Significant Other Observable Inputs (Level 2) [Member]
Restricted cash and investments:
Derivative assets	4,000	4,000
Derivative Financial Instruments, Assets [Member] | Significant Unobservable Inputs (Level 3) [Member]
Restricted cash and investments:
Derivative assets	0	0
Derivative Financial Instruments, Liabilities [Member]
Liabilities:
Derivative liabilities	10,000	(21,000)
Derivative Financial Instruments, Liabilities [Member] | Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member]
Liabilities:
Derivative liabilities	0	0
Derivative Financial Instruments, Liabilities [Member] | Significant Other Observable Inputs (Level 2) [Member]
Liabilities:
Derivative liabilities	10,000	(21,000)
Derivative Financial Instruments, Liabilities [Member] | Significant Unobservable Inputs (Level 3) [Member]
Liabilities:
Derivative liabilities	$ 0	$ 0

Fair Value (Schedule of Fair _2

Fair Value (Schedule of Fair Value, by Balance Sheet Grouping, Measured on Recurring Basis) (Details) - Recurring basis [Member] - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Assets:
Cash and cash equivalents	$ 434	$ 551
Other current assets	6	6
Other current assets	36	18
Total assets	476	575
Liabilities:
Accrued expenses	10	21
Total liabilities	10	(21)
Quoted Prices in Active Markets for Identical Instruments (Level 1) [Member]
Assets:
Cash and cash equivalents	434	551
Other current assets	1	1
Other current assets	0	0
Total assets	435	552
Liabilities:
Accrued expenses	0	0
Total liabilities	0	0
Significant Other Observable Inputs (Level 2) [Member]
Assets:
Cash and cash equivalents	0	0
Other current assets	5	5
Other current assets	0	0
Total assets	5	5
Liabilities:
Accrued expenses	10	21
Total liabilities	10	(21)
Significant Unobservable Inputs (Level 3) [Member]
Assets:
Cash and cash equivalents	0	0
Other current assets	0	0
Other current assets	36	18
Total assets	36	18
Liabilities:
Accrued expenses	0	0
Total liabilities	$ 0	$ 0

Fair Value (Schedule of Carryin

Fair Value (Schedule of Carrying Values and Estimated Fair Values of Debt Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Jul. 02, 2021
Debt Fair Value Disclosures
Less: current portion of debt	$ (235)	$ (245)
Long-term debt, less current portion, net of debt issuance costs	5,626	4,894
Reported Value Measurement [Member]
Debt Fair Value Disclosures
Long-term debt, gross	5,895	5,173
Debt issuance costs	(34)	(34)
Debt, net of debt issuance costs	5,861	5,139
Less: current portion of debt	(235)	(245)
Long-term debt, less current portion, net of debt issuance costs	5,626	4,894
Reported Value Measurement [Member] | Senior Notes 4.25 Percent Due March 2022 [Member]
Debt Fair Value Disclosures
Senior Notes	220	220
Reported Value Measurement [Member] | Senior Notes 4.75 Percent Due June 2023 [Member]
Debt Fair Value Disclosures
Senior Notes	541	541
Reported Value Measurement [Member] | Senior Notes 4.875 Percent Due March 2024 [Member]
Debt Fair Value Disclosures
Senior Notes	499	499
Reported Value Measurement [Member] | Senior Notes 4.75 Percent Due January 2025 [Member]
Debt Fair Value Disclosures
Senior Notes	479	479
Reported Value Measurement [Member] | Senior Notes 4.875 percent Due June 2027 [Member]
Debt Fair Value Disclosures
Senior Notes	504	504
Reported Value Measurement [Member] | Senior note 5.75 percent due December 2034 [Member]
Debt Fair Value Disclosures
Senior Notes	500	499
Reported Value Measurement [Member] | LIBOR based Term Loan Due September 2025 [Member]
Debt Fair Value Disclosures
Senior Notes	0	481
Reported Value Measurement [Member] | Senior note 4.091 percent due June 2029
Debt Fair Value Disclosures
Senior Notes	463	461
Reported Value Measurement [Member] | Senior note 5.75 percent due December 2034 [Member]
Debt Fair Value Disclosures
Senior Notes	489	489
Reported Value Measurement [Member] | Senior note 3.125 percent due July 2029 [Member]
Debt Fair Value Disclosures
Senior Notes	500	500
Reported Value Measurement [Member] | Senior Notes 3.375 Percent due July 2031 [Member]
Debt Fair Value Disclosures
Senior Notes	500	500
Reported Value Measurement [Member] | Term Loan A1
Debt Fair Value Disclosures
Senior Notes	600
Reported Value Measurement [Member] | Term Loan A2
Debt Fair Value Disclosures
Senior Notes	600
Estimate of Fair Value Measurement [Member]
Debt Fair Value Disclosures
Long-term debt, gross	6,155	5,487
Debt issuance costs	0	0
Debt, net of debt issuance costs	6,155	5,487
Less: current portion of debt	(236)	(249)
Long-term debt, less current portion, net of debt issuance costs	5,919	5,238
Estimate of Fair Value Measurement [Member] | Senior Notes 4.25 Percent Due March 2022 [Member]
Debt Fair Value Disclosures
Senior Notes	221	224
Estimate of Fair Value Measurement [Member] | Senior Notes 4.75 Percent Due June 2023 [Member]
Debt Fair Value Disclosures
Senior Notes	565	578
Estimate of Fair Value Measurement [Member] | Senior Notes 4.875 Percent Due March 2024 [Member]
Debt Fair Value Disclosures
Senior Notes	530	544
Estimate of Fair Value Measurement [Member] | Senior Notes 4.75 Percent Due January 2025 [Member]
Debt Fair Value Disclosures
Senior Notes	515	529
Estimate of Fair Value Measurement [Member] | Senior Notes 4.875 percent Due June 2027 [Member]
Debt Fair Value Disclosures
Senior Notes	554	561
Estimate of Fair Value Measurement [Member] | Senior note 5.75 percent due December 2034 [Member]
Debt Fair Value Disclosures
Senior Notes	522	513
Estimate of Fair Value Measurement [Member] | LIBOR based Term Loan Due September 2025 [Member]
Debt Fair Value Disclosures
Senior Notes	0	478
Estimate of Fair Value Measurement [Member] | Senior note 4.091 percent due June 2029
Debt Fair Value Disclosures
Senior Notes	521	519
Estimate of Fair Value Measurement [Member] | Senior note 5.75 percent due December 2034 [Member]
Debt Fair Value Disclosures
Senior Notes	567	566
Estimate of Fair Value Measurement [Member] | Senior note 3.125 percent due July 2029 [Member]
Debt Fair Value Disclosures
Senior Notes	490	488
Estimate of Fair Value Measurement [Member] | Senior Notes 3.375 Percent due July 2031 [Member]
Debt Fair Value Disclosures
Senior Notes	489	$ 487
Estimate of Fair Value Measurement [Member] | Term Loan A1
Debt Fair Value Disclosures
Senior Notes	589
Estimate of Fair Value Measurement [Member] | Term Loan A2
Debt Fair Value Disclosures
Senior Notes	$ 592

Fair Value (Narrative) (Details

Fair Value (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021	Jul. 02, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Income (loss) from equity method investments		$ 1	$ 3
Equity Method Investments	$ 81		81		$ 78
Net gains (losses) from investment under measurement alternative	2	$ (7)	4	$ 16
Cost-method investments [Member] | Other current assets [Member] | Fair Value, Measurements, Nonrecurring [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
Cost method investment	$ 88		$ 88		$ 117

Equity (Narrative) (Details)

Equity (Narrative) (Details)	6 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Equity [Abstract]
Authorized share capital (in dollars) | $	$ 13,500
Ordinary shares, authorized (in shares)	1,250,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.00001
Ordinary shares, outstanding (in shares)	219,463,688
Preferred shares, authorized (in shares)	100,000,000
Preferred shares, par value (in dollars per share) | $ / shares	$ 0.00001
Preferred shares, issued (in shares)	0
Preferred shares, outstanding (in shares)	0
Common stock, voting rights	one vote per share
Preferred stock minimum number of series	1
Stock repurchase program, remaining authorized repurchase amount | $	$ 3,300,000,000

Equity (Schedule of Share Repur

Equity (Schedule of Share Repurchases) (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Dollar Value [Abstract]
Repurchases of ordinary shares (in shares)			10
Tax withholding related to vesting of equity awards (in shares)			1
Repurchases of ordinary shares and tax withholding related to vesting of equity awards (in shares)			11
Repurchases of ordinary shares (1)	$ 480	$ 1,000	$ 905	$ 1,068
Tax withholding related to vesting of equity awards	$ 2	$ 1	45	$ 32
Repurchases of ordinary shares and tax withholding related to vesting of equity awards			$ 950

Revenue (Details)

Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 3,116	$ 2,623	$ 6,231	$ 4,937
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	1,433	1,306	3,016	2,412
Americas
Disaggregation of Revenue [Line Items]
Revenue	1,186	838	2,265	1,643
EMEA
Disaggregation of Revenue [Line Items]
Revenue	497	479	950	882
OEMs
Disaggregation of Revenue [Line Items]
Revenue	2,178	1,741	4,465	3,349
Distributors
Disaggregation of Revenue [Line Items]
Revenue	562	475	1,069	842
Retailers
Disaggregation of Revenue [Line Items]
Revenue	$ 376	$ 407	$ 697	$ 746

Guarantees Guarantees (Narrativ

Guarantees Guarantees (Narrative) (Details)	3 Months Ended
	Dec. 31, 2021
Minimum
Schedule of Fiscal Years [Line Items]
Product warranty period term	1 year
Maximum
Schedule of Fiscal Years [Line Items]
Product warranty period term	5 years

Guarantees (Product Warranty) (

Guarantees (Product Warranty) (Details) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021
Guarantees [Abstract]
Balance, beginning of period	$ 136	$ 151
Warranties issued	43	37
Repairs and replacements	(43)	(42)
Changes in liability for pre-existing warranties, including expirations	8	(9)
Balance, end of period	$ 144	$ 137

Earnings Per Share (Schedule of

Earnings Per Share (Schedule of computation of basic and diluted net income (loss) per share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Numerator:
Net income	$ 501	$ 280	$ 1,027	$ 503
Number of shares used in per share calculations:
Total shares for purposes of calculating basic net income per share	221	249	224	253
Weighted-average effect of dilutive securities:
Employee equity award plans	4	2	4	2
Total shares for purpose of calculating diluted net income per share	225	251	228	255
Net income per share:
Basic (in dollars per share)	$ 2.27	$ 1.12	$ 4.58	$ 1.99
Diluted (in dollars per share)	$ 2.23	$ 1.12	$ 4.50	$ 1.97

Commitments (Details)

Commitments (Details) $ in Millions	Dec. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
Unconditional purchase commitment	$ 495
2023	259
2024	162
2025	33
2026	26
Thereafter	$ 15

Subsequent event (Details)

Subsequent event (Details) - $ / shares	Jan. 26, 2022	Dec. 31, 2021	Jan. 01, 2021	Dec. 31, 2021	Jan. 01, 2021
Subsequent Event [Line Items]
Cash dividends declared per ordinary share (in dollars per share)		$ 0.70	$ 0.67	$ 1.37	$ 1.32
Common Stock | Subsequent Event
Subsequent Event [Line Items]
Cash dividends declared per ordinary share (in dollars per share)	$ 0.70
Dividends payable date	Apr. 6, 2022
Dividends payable, date of record	Mar. 22, 2022